Panacea Biotec Limited’s revenue in Q3FY23 fell 26% to ₹ 11,520 lakhs. Consolidated Profit After Tax came at ₹ 1,937 lakhs in Q3FY23. In this quarter’s results, the reports suggested that the firm has reported decreased revenues and the reason for the increased profitability is the income recieved from Exceptional Items.
Panacea Biotec Q3FY23; 26% Fall in Revenue
Tags: Pharmaceutical
Related Post
- Firstsource Solutions Q2 FY26 Earnings Results
Firstsource Solutions Ltd, a leading player in Business Process Management (BPM) and part of the…
-
Foseco India Q2 FY26 Earnings Results
Foseco India Ltd, incorporated in 1958 and engaged in manufacturing metallurgical additives and consumables that…
-
Force Motors Q2 FY26 Earnings Results
Force Motors Ltd, founded in 1958 and part of the Abhay Firodia Group, specializes in…